Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study

The Lancet

Volumn 391, Issue 10131, 2018, Pages 1706-1717

  Wang, Chen ^a,b,c,d,e   Xu, Jianying ^f   Yang, Lan ^g   Xu, Yongjian ^h   Zhang, Xiangyan ⁱ   Bai, Chunxue ^j   Kang, Jian ^k   Ran, Pixin ^l,m   Shen, Huahao ⁿ   Wen, Fuqiang ^o   Huang, Kewu ^p,q   Yao, Wanzhen ^r   Sun, Tieying ^b,s,t   Shan, Guangliang ^u   Yang, Ting ^a,b,d,o   Lin, Yingxiang ^p,q   Wu, Sinan ^a,b   Zhu, Jianguo ^b,s   Wang, Ruiying ^f   Shi, Zhihong ^g   Zhao, Jianping ^h   Ye, Xianwei ⁱ   Song, Yuanlin ^j   Wang, Qiuyue ^k   Zhou, Yumin ^l,m   Ding, Liren ⁿ   Chen, Yahong ^r   Guo, Yanfei ^b,s,t   Xiao, Fei ^b,s,t   Lu, Yong ^p,q   Peng, Xiaoxia ^v   Zhang, Biao ^u   Xiao, Dan ^a,b,e   Chen, Chung Shiuan ^w   Wang, Zuomin ^p,q   Zhang, Hong ^p,q   Bu, Xiaoning ^p,q   Zhang, Xiaolei ^a,b,d   An, Li ^p,q   Zhang, Shu ^p,q   Cao, Zhixin ^p,q   Zhan, Qingyuan ^a,b,d   Yang, Yuanhua ^p,q   Cao, Bin ^a,b,d   Dai, Huaping ^a,b,d   Liang, Lirong ^p,q   He, Jiang ^w   more..

^a Clinical Research Institute of China   (China)

^b National Clinical Research Centre for Respiratory Disease   (China)

^c PEKING UNION MEDICAL COLLEGE   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e WHO Collaborating Centre for Tobacco Cessation and Respiratory Diseases Prevention   (China)

^f Shanxi Dayi Hospital   (China)

^g THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^h HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

ⁱ GUIZHOU PROVINCIAL PEOPLE'S HOSPITAL   (China)

^j FUDAN UNIVERSITY   (China)

^k CHINA MEDICAL UNIVERSITY   (China)

^l GUANGZHOU MEDICAL UNIVERSITY   (China)

^m National Clinical Research Center for Respiratory Disease   (China)

ⁿ THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^o SICHUAN UNIVERSITY   (China)

^p CAPITAL MEDICAL UNIVERSITY   (China)

^q Beijing Institute of Respiratory Medicine   (China)

^r PEKING UNIVERSITY THIRD HOSPITAL   (China)

^s BEIJING HOSPITAL   (China)

^t National Center of Gerontology   (China)

^u INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^v CAPITAL MEDICAL UNIVERSITY   (China)

^w TULANE UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; SALBUTAMOL;

ADULT; AGED; AIR POLLUTION; CHINA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CROSS-SECTIONAL STUDY; DRUG EFFECT; EXPOSURE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION TEST; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PARTICULATE MATTER; PATHOPHYSIOLOGY; PREVALENCE; PREVENTION AND CONTROL; PROCEDURES; RISK FACTOR; SMOKING; VITAL CAPACITY;

ADMINISTRATION, INHALATION; ADULT; AGED; AIR POLLUTION; ALBUTEROL; BRONCHODILATOR AGENTS; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INHALATION EXPOSURE; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PARTICULATE MATTER; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SMOKING; VITAL CAPACITY;

EID: 85045110568     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(18)30841-9     Document Type: Article

References (37)

1. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388 (2016), 1545–1602.
2. GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med 5 (2017), 691–706.
3. Adeloye, D, Chua, S, Lee, C, et al. Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Glob Health, 5, 2015, 020415.
4. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388 (2016), 1459–1544.
5. Zhou, M, Wang, H, Zhu, J, et al. Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet 387 (2016), 251–272.
6. Zhong, N, Wang, C, Yao, W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med 176 (2007), 753–760.
7. He, MZ, Zeng, X, Zhang, K, Kinney, PL, Fine particulate matter concentrations in urban Chinese cities, 2005–2016: a systematic review. Int J Environ Res Public Health, 14, 2017, 191.
8. Guan, WJ, Zheng, XY, Chung, KF, Zhong, NS, Impact of air pollution on the burden of chronic respiratory diseases in China: time for urgent action. Lancet 388 (2016), 1939–1951.
9. Bi, Y, Jiang, Y, He, J, et al. Status of cardiovascular health in Chinese adults. J Am Coll Cardiol 65 (2015), 1013–1025.
10. Cerveri, I, Corsico, AG, Accordini, S, et al. Underestimation of airflow obstruction among young adults using FEV1/FVC <70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes. Thorax 63 (2008), 1040–1045.
11. National Bureau of Statistics of China. 2010 Population Census. http://www.stats.gov.cn/english/Statisticaldata/CensusData/, April 23, 2013 (accessed April 3, 2018).
12. Vogelmeier, CF, Criner, GJ, Martinez, FJ, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD executive summary. Am J Respir Crit Care Med 195 (2017), 557–582.
13. 2·5 concentrations: China, 2004–2013. Environ Health Perspect 124 (2016), 184–192.
14. Miller, MR, Hankinson, J, Brusasco, V, et al. Standardisation of spirometry. Eur Respir J 26 (2005), 319–338.
15. Hankinson, JL, Odencrantz, JR, Fedan, KB, Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 159 (1999), 179–187.
16. Jian, W, Gao, Y, Hao, C, et al. Reference values for spirometry in Chinese aged 4–80 years. J Thorac Dis 9 (2017), 4538–4549.
17. Newcombe, RG, Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 17 (1998), 857–872.
18. National Center for Health Statistics. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988–94. Vital Health Stat 1 32 (1994), 1–407.
19. Brick, JM, Kalton, G, Handling missing data in survey research. Stat Methods Med Res 5 (1996), 215–238.
20. National Bureau of Statistics of China. 2016 China Statistical Yearbook. http://www.stats.gov.cn/tjsj/ndsj/2016/indexeh.htm, 2016 (accessed April 3, 2018).
21. Menezes, AM, Perez-Padilla, R, Jardim, JR, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 366 (2005), 1875–1881.
22. Buist, AS, McBurnie, MA, Vollmer, WM, et al. International variation in the prevalence of COPD (the BOLD study): a population-based prevalence study. Lancet 370 (2007), 741–750.
23. Tilert, T, Dillon, C, Paulose-Ram, R, Hnizdo, E, Doney, B, Estimating the US prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007–2010. Respir Res, 14, 2013, 103.
24. Gershon, AS, Warner, L, Cascagnette, P, Victor, JC, To, T, Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study. Lancet 378 (2011), 991–996.
25. Mannino, DM, Buist, AS, Global burden of COPD: risk factors, prevalence, and future trends. Lancet 370 (2007), 765–773.
26. Yin, P, Jiang, CQ, Cheng, KK, et al. Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study. Lancet 370 (2007), 751–757.
27. Hagstad, S, Bjerg, A, Ekerljung, L, et al. Passive smoking exposure is associated with increased risk of COPD in never smokers. Chest 145 (2014), 1298–1304.
28. Liu, S, Zhou, Y, Liu, S, et al. Association between exposure to ambient particulate matter and chronic obstructive pulmonary disease: results from a cross-sectional study in China. Thorax 72 (2017), 788–795.
29. Schikowski, T, Adam, M, Marcon, A, et al. Association of ambient air pollution with the prevalence and incidence of COPD. Eur Respir J 44 (2014), 614–626.
30. Fuertes, E, Bracher, J, Flexeder, C, et al. Long-term air pollution exposure and lung function in 15 year-old adolescents living in an urban and rural area in Germany: the GINIplus and LISAplus cohorts. Int J Hyg Environ Health 218 (2015), 656–665.
31. Islam, T, Gauderman, WJ, Berhane, K, et al. Relationship between air pollution, lung function and asthma in adolescents. Thorax 62 (2007), 957–963.
32. Assad, NA, Kapoor, V, Sood, A, Biomass smoke exposure and chronic lung disease. Curr Opin Pulm Med 22 (2016), 150–157.
33. Sobrino, E, Irazola, VE, Gutierrez, L, et al. Estimating prevalence of chronic obstructive pulmonary disease in the Southern Cone of Latin America: how different spirometric criteria may affect disease burden and health policies. BMC Pulm Med, 17, 2017, 187.
34. Prescott, E, Vestbo, J, Socioeconomic status and chronic obstructive pulmonary disease. Thorax 54 (1999), 737–741.
35. Li, Y, Yang, L, Wang, L, et al. Burden of hypertension in China: a nationally representative survey of 174 621 adults. Int J Cardiol 227 (2017), 516–523.
36. Xu, Y, Wang, L, He, J, et al. Prevalence and control of diabetes in Chinese adults. JAMA 310 (2013), 948–959.
37. National Health and Family Planning Commission of the People's Republic of China. The 13th Five-Year Plan for Healthcare. http://www.gov.cn/zhengce/content/2017-01/10/content_5158488.htm, Dec 27, 2016 (accessed Sept 20, 2017; in Chinese).